Can GLP-1 Drug Reduce Risk Of Heart Failure? Recent Study Reveals 40% Chances
Offering a glimpse of hope, a new study published in the Journal of the American Medical Association (JAMA) highlights that use of glucagon-like peptide-1 (GLP-1) medications may reduce the risk of hospitalization and all-cause mortality by over 40% in individuals suffering from type-2 diabetes with severe forms of heart failure.